[WP-28-1] Development of PSMA-targeting agent using astatin-211

Tomoki Yamashita¹、Yuta Kaizuka¹、Mizuki Hirayama¹、Takahiro Yasuda¹、Kazuhiro Takahashi²、Hiroyuki Suzuki¹、Tomoya Uehara¹ (1.Graduate Shool Of Pharmaceutical Sciences, Chiba University、2.Fukushima Medical University)

[WP-28-2] Development of metabotropic glutamate receptor 1-targeted radiopharmaceuticals for theranostics of melanoma

Lin Xie、Masayuki Hanyu、Masayuki Fujinaga、Lulu Zhang、Yiding Zhang、Mori Wakana、Kuan Hu、Katsuyuki Minegishi、Kotaro Nagatsu、Ming-Rong Zhang (Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology)

[WP-28-3] Synthesis and evaluation of At-211 labeled TRT-radiopharmaceuticals (At-AITM) for melanoma with overexpressed metabotropic glutamate receptor 1

Masayuki Hanyu¹、Lin Xie¹、Yiding Zhang¹、Katsuyuki Minegishi¹、Ayumi Kadoma¹、Kuan Hu¹、Masayuki Fujinaga¹、Kotaro Nagatsu¹、Noriko Ishioka²、M.R Zhang¹ (1.Department of Advanced Nuclear Medicine science, Quantum Life and Medicine Science Directorate, National Institute for Quantum Science and Technology、2.Department of Radiation-Applied Biology Research, National Institute for Quantum Science and Technology)

[WP-28-4] Radiochemical and pharmacokinetic studies of aminopolycarboxylate chelators to remove unexpectedly accumulated free 225Ac in the liver and whole body for targeted alpha therapy

Mitsuhiro Shinada¹、Mitsuyoshi Yoshimoto³、Yukie Yoshii¹、Hiroki Matsumoto¹、Masashi Takahashi^1,2、Chika Igarashi¹、Fukiko Hihara¹、Tomoko Tachibana¹、Hirofumi Fujii³、Koshin Washiyama⁴ (1.National Insitutes For Quantum Science And Technology、2.Faculty of Science, Toho University、3.Division of Functional Imaging, National Cancer Center Hospital East、4.Advanced Clinical Research Center, Fukushima Medical University)

[WP-28-5] Development of brachytherapy agents using thermo-sensitive polymer nanocarrier

Akira Makino、Tetsuya Mori、Hidehiko Okazawa、Yasushi Kiyono (University of Fukui)

[WP-28-6] Efficacy of vorinostat-sensitized intraperitoneal radioimmunotherapy with 64Cu-labeled cetuximab in mouse model of peritoneal dissemination of gastric cancer in vivo

Tomoko Tachibana^1,2、Hiroki Matsumoto¹、Fukiko Hihara¹、Chika Igarashi¹、Mitsuhiro Shinada^1,2、MingRong Zhang¹、Toshihiko Kishimoto²、Tatsuya Higashi¹、Yukie Yoshii¹ (1.National Institutes For Quantum Science And Technology、2.Faculty of Science, Toho University)

[WP-28-7] In vitro tumor cell-binding assay to select high-binding antibody and predict therapy response for personalized 64Cu-intraperitoneal radioimmunotherapy against peritoneal dissemination of pancreatic cancer.

Fukiko Hihara¹、Hiroki Matsumoto^1,4、Takashi Masuko²、Yuichi Endo Endo²、Chika Igarashi¹、Tomoko Tachibana¹、Gene Kurosawa³、Aya Sugyo¹、Atsushi B. Tsuji Tsuji¹、Yukie Yoshii¹ (1.National Institutes for Quantum Science and Technology、2. School of Pharmacy, Kindai University、3.International Center for Cell and Gene Therapy, Fujita Health University、4.Department of Diagnostic Radiology, Kanagawa Cancer Center)

[WP-28-8] Development of α-methylated 3-boronophenylalanine derivatives with improved LAT1/LAT2 selectivity for BNCT.

Fuko Hirano¹、Naoya Kondo¹、Yusuke Murata²、Aya Sudani²、Takashi Temma¹ (1.Osaka Medical and Pharmaceutical University、2.Stella Pharma Corporation Sakai R&D Center)

[WP-28-9] Development of theranostic probes for boron neutron capture therapy and companion diagnosis

Sayaka Imai¹、Yuki Ematsu¹、Kenji Mishiro²、Takeshi Fuchigami¹、Seigo Kinuya³、Kazuma Ogawa^1,2 (1.Graduate School of Medical Sciences, Kanazawa University、2.Institute for Frontier Science Initiative, Kanazawa University、3.Department of Nuclear Medicine, Kanazawa University Hospital)

[WP-28-10] High brain permeability for 11C-labeled peretinoin, guiding to expose drug's novel CNS activity

Keiichi Suzuki¹、Hiroko Koyama^1,2、Aya Ogata³、Yasuyuki Kimura³、Hideki Ishii⁴、Yuji Nagai⁴、Hiroshi Katsuki⁵、Tetsuya Kimura⁶、Takashi Kato³、Masaaki Suzuki³ (1.United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University、2.Faculty of Engineering, Gifu University、3.National Center for Geriatrics and Gerontology、4.National Institutes for Quantum and Radiological Science and Technology、5.Graduate School of Pharmaceutical Sciences School of Pharmacy, Kumamoto University、6.Tokyo Metropolitan Institute of Gerontology)

[WP-28-11] Successful encapsulation of ⁹⁰Y/¹¹¹In in liposomes and their potential as radio-theranostics agents

Izumi Umeda, O.¹、Atsushi Yagishita¹、Miho Katsuragawa¹、Shin'ichiro Takeda¹、Motohiro Kojima²、Hirofumi Fujii²、Tadayuki Takahashi¹ (1.Kavli IPMU, University of Tokyo、2.EPOC, National Cancer Center)

[WP-28-12] Targeted alpha therapy against antibody-drug resistant peritoneal metastasis of uterine serous carcinoma

Huizi Li¹、Mayuka Anko²、Sumitaka Hasegawa¹ (1.National Institute for Quantum Science and Technology、2.Keio University School of Medicine)

Session information

Nuclear Medicine Innovation1

Therapy